Therapeutic Plasma Exchange in Pediatric Patients: Results from a Single Center
dc.contributor.author | Dalkiran, Tahir | |
dc.contributor.author | Mercan, Mehmet | |
dc.contributor.author | Ipek, Sevcan | |
dc.contributor.author | Gullu, Ufuk Utku | |
dc.contributor.author | Kandur, Yasar | |
dc.contributor.author | Acipayam, Can | |
dc.contributor.author | Dilber, Cengiz | |
dc.date.accessioned | 2025-01-21T16:55:25Z | |
dc.date.available | 2025-01-21T16:55:25Z | |
dc.date.issued | 2024 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Therapeutic plasma exchange (TPE) can be applied as an effective therapeutic option in children with hematological, neurological, nephrological, and autoimmune/rheumatic disorders. We aimed to report our TPE experience in pediatric patients. In this article, we retrospectively reviewed the records of pediatric patients who underwent TPE between 2019 and 2021. A total of 128 TPE sessions were performed in 25 patients (13 males,12 females; mean age 59.6 +/- 11.7 [3-198] months). The TPE indications were sepsis with/without multiorgan dysfunction syndrome in five patients, acute liver failure, hemolytic uremic syndrome caused by Shiga toxin, and autoimmune hemolytic anemia in three patients, respectively, multiple sclerosis, autoimmune encephalitis, and multisystem inflammatory syndrome in children (MIS-C) in two patients each, and myasthenia gravis crisis, meningococcemia, hemolytic uremic syndrome caused by coronavirus disease 2019, hemophagocytic lymphohistiocytosis, autoimmune encephalitis, and metabolic disease (fatty acid oxidation defect, liver failure) in one patient each. Based on our findings, we proposed that the American Society for Apheresis criteria should be updated according to newly described clinical conditions such as MIS-C. | |
dc.identifier.doi | 10.1055/s-0041-1742252 | |
dc.identifier.endpage | 285 | |
dc.identifier.issn | 2146-4618 | |
dc.identifier.issn | 2146-4626 | |
dc.identifier.issue | 3 | |
dc.identifier.pmid | 39629152 | |
dc.identifier.startpage | 282 | |
dc.identifier.uri | https://doi.org/10.1055/s-0041-1742252 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/25779 | |
dc.identifier.volume | 13 | |
dc.identifier.wos | WOS:000750544400002 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Georg Thieme Verlag Kg | |
dc.relation.ispartof | Journal of Pediatric Intensive Care | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241229 | |
dc.subject | therapeutic plasma exchange; American Society for Apheresis guidelines; multisystem inflammatory syndrome in children | |
dc.title | Therapeutic Plasma Exchange in Pediatric Patients: Results from a Single Center | |
dc.type | Article |